Insider Transactions in Q2 2023 at Moleculin Biotech, Inc. (MBRX)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 20
2023
|
Walter V Klemp CEO and President |
SELL
Payment of exercise price or tax liability
|
Direct |
13,697
-2.82%
|
$0
$0.57 P/Share
|
|
Jun 20
2023
|
Walter V Klemp CEO and President |
BUY
Exercise of conversion of derivative security
|
Direct |
56,250
+10.39%
|
-
|
|
Jun 20
2023
|
Jonathan P. Foster Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
9,676
-15.8%
|
$0
$0.57 P/Share
|
|
Jun 20
2023
|
Jonathan P. Foster Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
40,667
+39.9%
|
-
|
|
Jun 20
2023
|
Donald H Picker Chief Science Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,267
-4.53%
|
$0
$0.57 P/Share
|
|
Jun 20
2023
|
Donald H Picker Chief Science Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
16,167
+14.64%
|
-
|
|
Jun 16
2023
|
Walter V Klemp CEO and President |
SELL
Payment of exercise price or tax liability
|
Direct |
6,088
-1.4%
|
$0
$0.57 P/Share
|
|
Jun 16
2023
|
Walter V Klemp CEO and President |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+5.44%
|
-
|
|
Jun 16
2023
|
Jonathan P. Foster Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,044
-12.89%
|
$0
$0.57 P/Share
|
|
Jun 16
2023
|
Jonathan P. Foster Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+34.6%
|
-
|